Golnaz has 10+ years’ experience in biotech and medtech research and industry. She holds a PhD in Analytical Biotechnology from Cambridge University followed by several years of research in physiology at Cambridge and Oxford universities in collaboration with Pharmaceuticals. For the last 5 years, Golnaz has been in Commercialization, Technology & Market Assessment, Competitor Analysis and Business Evaluation in life science industry and has been advisor to life science investors. She is certified in Executive Finance from Harvard Business School.

(June 2017)